Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.

Hainsworth JD, Spigel DR, Sosman JA, Burris HA, Farley C, Cucullu H, Yost K, Hart LL, Sylvester L, Waterhouse DM, Greco FA
Clin Genitourin Cancer. 2007 5 (7): 427-32

PMID: 18272024 · DOI:10.3816/CGC.2007.n.030

MeSH Terms (22)

Adult Aged Aged, 80 and over Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Benzamides Bevacizumab Carcinoma, Renal Cell ErbB Receptors Erlotinib Hydrochloride Female Humans Imatinib Mesylate Kidney Neoplasms Male Middle Aged Piperazines Pyrimidines Quinazolines Receptors, Platelet-Derived Growth Factor Receptors, Vascular Endothelial Growth Factor

Connections (1)

This publication is referenced by other Labnodes entities:

Links